Patents Assigned to Taigen Biotechnology
  • Pyrimidine compounds
    Patent number: 7589197
    Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
    Type: Grant
    Filed: June 13, 2006
    Date of Patent: September 15, 2009
    Assignee: Taigen Biotechnology
    Inventors: Chi-Feng Yen, Cheng-Kung Hu, Ming-Chen Chou, Chen-Tso Tseng, Chien-Huang Wu, Ying-Huey Huang, Shu-Jen Chen, Chi-Hsin Richard King
  • Synthesis of polyamine compounds
    Patent number: 7501526
    Abstract: This invention relates to methods of preparing the compounds of formula (V): Each variable in this formula is defined in the specification.
    Type: Grant
    Filed: January 20, 2005
    Date of Patent: March 10, 2009
    Assignee: Taigen Biotechnology
    Inventors: Chien-Huang Wu, Jia-Liang Zhu, Chen-Tso Tseng, Chi-Feng Yen, Kak-Shan Shia, Yibin Xiang, Gholam Hossein Hakimelahi, Ming-Chen Chou
  • Polyamine compounds for treating chemokine receptor mediated diseases
    Patent number: 7399776
    Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
    Type: Grant
    Filed: March 30, 2004
    Date of Patent: July 15, 2008
    Assignee: Taigen Biotechnology
    Inventors: Kak-Shan Shia, Gholam Hossein Hakimelahi, Jia-Liang Zhu, Chi-Feng Yen, Ying-Huey Huang, Yibin Xiang, Hua-Chien Chen, Ching-Cheng Wang
  • Protease inhibitors
    Patent number: 7304088
    Abstract: This invention relates to treating an infection with a virus using protease inhibitors. Examples of the protease inhibitors include compounds of formula (I).
    Type: Grant
    Filed: December 29, 2004
    Date of Patent: December 4, 2007
    Assignee: TaiGen Biotechnology
    Inventors: Syaulan Yang, Jen-Dar Wu, Feng-Yih Su, Chun-Wei Kuo, Wen-Chang Chen, Yibin Xiang, Ching-Cheng Wang, Shao-Ying Liao
  • Aminoquinoline compounds
    Patent number: 7183413
    Abstract: This invention relates to treating inflammatory and immune diseases with certain aminoquinoline compounds that bind to CXCR3 receptors. The aminoquinoline compounds are covered by the formula (I) shown below. Each variable is defined in the specification.
    Type: Grant
    Filed: April 6, 2004
    Date of Patent: February 27, 2007
    Assignee: Taigen Biotechnology
    Inventors: Chu-Chung Lin, Jen-Fuh Liu, Chih-Wei Chang, Shu-Jen Chen, Yibin Xiang, Pei-Chin Cheng, Jiing-Jyh Jan